BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6995285)

  • 1. Types of spontaneous nalidixic acid resistant mutants of Escherichia coli.
    Kumar S
    Indian J Exp Biol; 1980 Apr; 18(4):341-3. PubMed ID: 6995285
    [No Abstract]   [Full Text] [Related]  

  • 2. [Resistance to nalidixic acid in tetracycline-resistant mutants of E. coli].
    Khanina MF; Gromova TG; Terekhov AA
    Antibiotiki; 1975; 20(12):1099-104. PubMed ID: 773284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid.
    Cattoir V; Lesprit P; Lascols C; Denamur E; Legrand P; Soussy CJ; Cambau E
    J Antimicrob Chemother; 2006 Nov; 58(5):1054-7. PubMed ID: 16984897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nalidixic acid on recombination and DNA repair of Escherichia coli K-12 strains.
    Inan S; Kalaycioglu A
    Indian J Exp Biol; 1996 Oct; 34(10):949-53. PubMed ID: 9055644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [DNA content in Escherichia coli mutants resistant to rifampicin and nalidixic acid].
    Korotiaev AI; Krolichenko TP
    Mikrobiologiia; 1982; 51(6):983-5. PubMed ID: 6759888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antimicrobial action of nalidixic acid and the effect on the elimination of resident drug-resistant Shigella and E. coli in mice].
    Ogasawara K; Ata S; Kasuya M; Kobayashi T
    Igaku To Seibutsugaku; 1965 Jun; 70(6):343-8. PubMed ID: 5318841
    [No Abstract]   [Full Text] [Related]  

  • 7. Mutation affecting resistance of Escherichia coli K12 to nalidixic acid.
    Hrebenda J; Heleszko H; Brzostek K; Bielecki J
    J Gen Microbiol; 1985 Sep; 131(9):2285-92. PubMed ID: 3906038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of high mutation rates in experimental populations of E. coli.
    Sniegowski PD; Gerrish PJ; Lenski RE
    Nature; 1997 Jun; 387(6634):703-5. PubMed ID: 9192894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are quinolone-resistant uropathogenic Escherichia coli less virulent?
    Vila J; Simon K; Ruiz J; Horcajada JP; Velasco M; Barranco M; Moreno A; Mensa J
    J Infect Dis; 2002 Oct; 186(7):1039-42. PubMed ID: 12232848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Character of the effect of nalidixic acid (negram) on Escherichia coli strain 613].
    Planel'es KhKh; Andreeva AM; Moroz AF
    Antibiotiki; 1968 Jul; 13(7):617-20. PubMed ID: 4880236
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mutations of gyrA in ciprofloxacin resistant Escherichia coli strains].
    Eraç B; Gill A; Amyes SG; Gülay Z
    Mikrobiyol Bul; 2003; 37(2-3):125-30. PubMed ID: 14593893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro selection of Escherichia coli mutants with decreased susceptibility to norfloxacin.
    Forsgren A; Striby AC
    Scand J Infect Dis; 1988; 20(5):531-4. PubMed ID: 3065926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mutant of Escherichia coli hyper-resistant to a number of DNA damaging agents: location of the mutational site.
    Ahmad SI
    J Photochem Photobiol B; 1996 Oct; 36(1):47-53. PubMed ID: 8988611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive R plasmid mutator effect on chromosomal mutation to nalidixic acid resistance in nalidixic acid-exposed cultures of Escherichia coli.
    Ambler JE; Pinney RJ
    J Antimicrob Chemother; 1995 May; 35(5):603-9. PubMed ID: 7592173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquisition and epidemiology of antibiotic-resistant Escherichia coli in a cohort of newborn calves.
    Hoyle DV; Knight HI; Shaw DJ; Hillman K; Pearce MC; Low JC; Gunn GJ; Woolhouse ME
    J Antimicrob Chemother; 2004 May; 53(5):867-71. PubMed ID: 15056641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sensitivity of an E. coli strain during therapy of experimental pyelonephritis using nalidixic acid].
    Hatala M; Ritzerfeld W; Prát V; Konícková L; Losse H
    Cas Lek Cesk; 1970 Mar; 109(14):291-6. PubMed ID: 4909024
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on mutational cross-resistance between ciprofloxacin, novobiocin and coumermycin in Escherichia coli and Staphylococcus warneri.
    Howard BM; Pinney RJ; Smith JT
    Microbios; 1993; 75(304):185-95. PubMed ID: 8246811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms of onset of quinolone-resistant mutants in E. coli strains].
    Matinca D; Serban O
    Bacteriol Virusol Parazitol Epidemiol; 2003; 48(2-3):169-70. PubMed ID: 15341335
    [No Abstract]   [Full Text] [Related]  

  • 19. Nalidixic acid-resistant auxotrophs of Escherichia coli.
    Helling RB; Adams BS
    J Bacteriol; 1970 Nov; 104(2):1027-9. PubMed ID: 4923064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nalidixic acd-resistant mutants of Escherichia coli deficient in isocitrate dehydrogenase.
    Helling RB; Kukora JS
    J Bacteriol; 1971 Mar; 105(3):1224-6. PubMed ID: 4926678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.